Regulators call for unified AI guidelines in drug development at RAPS Convergence 2026
read at raps ↗RegulatoryNeutral
Regulators and industry experts gathered at RAPS Convergence 2026 in Charlotte, NC to discuss the growing role of artificial intelligence in drug development.
The panel highlighted that differing regulatory expectations across jurisdictions could hinder the responsible use of AI, urging a coordinated approach.
Participants called for the creation of common standards and clear guidance to ensure AI tools are validated, transparent, and aligned with patient safety priorities.
They noted that such harmonization would help companies adopt AI more efficiently while maintaining compliance.
source
This writeup was produced by pharmadog from original reporting by raps.
Original headline: “Convergence: Regulators emphasize need for harmonized approach to AI”
read at raps ↗
comments(0)
5-min edit window · permanent after that